Dassault Systèmes to Showcase the Virtual Twin Experience of the Human Body at CES 2022

• CES visitors can “meet” their virtual twin at booth #8715 in the LVCC’s North Hall
• Three interactive experiences will reveal the possibilities that virtual twins of the human body bring to health care
• The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated

LAS VEGAS--(BUSINESS WIRE)--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced it will enable CES 2022 attendees to “meet” their virtual twin and see the possibilities that virtual twins of the human body bring to health care, January 5-8, 2022 in Las Vegas.

Visitors to Dassault Systèmes’ booth #8715 in the Las Vegas Convention Center’s North Hall will go on a journey where they engage in three interactive experiences showcasing the virtual twin experience of the human body – the next horizon in life sciences and healthcare that makes it possible to visualize, test, understand and predict what cannot be seen, from the way drugs affect a disease to surgical outcomes before a patient is treated.

The journey begins with a volumetric light experience that, starting from a photo taken of a visitor, displays a larger-than-life virtual twin of their head. This mirror image becomes translucent until it reveals a rotatable brain that pulsates in colors and patterns symbolizing various disease states. Next, the visitor will see an animation of the heart. With every heartbeat, the virtual twin increases in size until it expands into particles revealing the silhouette of the visitor, who can dance and move to interact with their virtual twin before it dissolves into a data cloud.

The visitor will then participate in augmented reality experiences that demonstrate the Living Heart and the Living Brain – two initiatives currently being used by researchers, device manufacturers and doctors to develop highly accurate virtual models for reproducing conditions and testing treatment options. The visitor can hold, rotate, and squeeze a 3D-printed replica of a heart and a brain, each with embedded sensors and processing components, and see their actions mirrored in a virtual twin on a connected touchscreen in real time. The physical heart model measures the visitor’s heart rate, while the model’s virtual twin pulsates to match the visitor’s heartbeat and displays their heart rate on the screen. As the visitor interacts with the physical model of the brain, they can explore its hemispheres on the virtual twin, and learn more about their function.

###

FOR MORE INFORMATION

Dassault Systèmes at CES 2022: https://events.3ds.com/ces-2022

Video teaser: https://www.youtube.com/watch?v=I4Zdszzp77Q

Dassault Systèmes’ 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com

SHARE THIS ON TWITTER

Attending #CES 2022? “Meet” your virtual twin & see what virtual twins of the human body bring to health care at booth #8715 LVCC North Hall @Dassault3DS #3DEXPERIENCE

Connect with Dassault Systèmes on
Twitter    Facebook    LinkedIn    Youtube

ABOUT DASSAULT SYSTÈMES
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 290,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.